Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
US |
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
US |
|
International Business Machines Corp
NYSE:IBM
|
US |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
American Eagle Outfitters Inc
NYSE:AEO
|
US |
|
Pinterest Inc
NYSE:PINS
|
US |
|
T
|
Telefonica SA
XMUN:TNE2
|
ES |
|
Chailease Holding Company Ltd
TWSE:5871
|
TW |
Wall St Price Targets
ALNY Price Targets Summary
Alnylam Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ALNY is 454.33 USD with a low forecast of 238.36 USD and a high forecast of 594.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALNY's stock price target?
Price Target
454.33
USD
According to Wall Street analysts, the average 1-year price target for ALNY is 454.33 USD with a low forecast of 238.36 USD and a high forecast of 594.3 USD.
What is the Revenue forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 18%.
What is the Operating Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
37%
The compound annual growth rate for Operating Income over the next 8 years is 37%.
What is the Net Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
39%
The compound annual growth rate for Net Income over the next 8 years is 39%.
